INSIGHT PROVIDER
Top 5%
Xinyao (Criss) Wang

Xinyao (Criss) Wang
HK/China Healthcare Analyst (ex-Fosun Pharma)

948
Insights
316.7k
Views
426
Followers
China Health Care Equity Bottom-Up Thematic (Sector/Industry)
Refresh
19 Apr 2024 09:16
Smartkarma Originals

China Population Policies Impact on Healthcare Companies Series – Part 4

​Different provinces expand coverage for assisted reproductive services in medical insurance. Livzon missed expectation in 2023.US sanction on BGI...

Share
18 Apr 2024 08:55

Pre-IPO Belle Fashion Group - Performance Has Picked Up, but Not yet Reversed

After years of accumulation/continuous optimization, Belle’s DTC omnichannel retail network has solidified foundation of performance growth. But...

Share
17 Apr 2024 08:55

Pre-IPO BenQ BM Holding - Profitability Will Be Disappointing Due To "Flaws" In Business Model

​General hospitals like BenQ face challenges due to their business model, with low profits and difficulty attracting/retaining talent, leading to...

Share
16 Apr 2024 08:55

2024 High Conviction Update: Innovent (1801.HK) - Breakeven Is Still on Track Despite Soaring Costs

Loose cost control led to an expansion of losses in 23H2, but the goal of breakeven in 2025 is still within the plan, which could be achieved...

Share
15 Apr 2024 08:57

Escalation of Israel-Hamas War - Here's How Investors Should Position Themselves in Dramatic Changes

Iran's attack on Israel is just the start.The escalation of Middle East conflict seems inevitable. In 24H2, we may see a series of "beyond...

Share
x